Press release
Animal Replacement Technologies - Stock Offering
Dr. Christopher Sakezles, President and Chief Technology Officer of Animal Replacement Technologies
Animal Replacement Technologies is a high-tech startup company based in Sarasota, Florida that develops the world's most sophisticated synthetic human cadavers, body parts, and tissues. These patented and award-winning products employ replaceable muscles, tendons, veins, arteries, and organs, all made from novel materials that mimic the structural, chemical, and mechanical properties of discrete living tissues. Such products are used by Fortune 500 medical device manufacturers to replace live animals in product development tests, by hospitals in surgical simulation, and by university medical schools in medical training.
Developers, researchers, and educators use Animal Replacement Technologies' products to perform highly compelling benchmarking studies. Such tests allow the developer to illustrate performance differences between prototype variants or prototypes and previously released devices. Used in this capacity, these products are the best tool available for supporting substantial equivalence claims to the FDA.
"There is no rubber, glass, or plastic in our products", says Dr. Christopher Sakezles, the President of Animal Replacement Technologies. "Each one of our extensive library of synthetic human tissues is designed on the basis of tests performed on live tissue, and much like the real thing our tissue analogs are composed of water, fibers, and salts. In fact, each component we make, such as an individual sartorius muscle, is itself comprised of multiple complex constructions . . . these are by far the world's most sophisticated synthetic body parts."
Dr. Christopher Sakezles
President, Chief Technology Officer
Animal Replacement Technologies
2522 Trailmate Drive
Sarasota, Florida 34243
Main: 941-727-0488
Fax: 941-727-0489
www.anireptec.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Animal Replacement Technologies - Stock Offering here
News-ID: 23919 • Views: …
More Releases from Animal Replacement Technologies
Synthetic Human Tissues E-Commerce Site
Animal Replacement Technologies announced today the launch of their E-commerce site (store.anireptec.com) for North America and Europe. A full range of synthetic human tissues and body parts are now available for purchase on the site via, credit card, check, or purchase order.
Animal Replacement Technologies, based in Florida, USA, develops sophisticated synthetic human tissues and body parts for the medical device, consumer product, and military technology industries. This technology employs replacable…
Animal Replacement Technologies - Convertible Bond Offering
Animal Replacement Technologies announced today the availability of $1 million USD in convertible bonds in conjunction with their IPO (Initial Private Offering). These securities will pay 15% annually in quarterly installments and may be exchanged for common stock either upon demand or at the company\'s first organized equity offering (scheduled for late 2008). This opportunity is open to individuals, business entities, and educational institutions, and will involve up to $1…
Second Generation Vascular Lesion Models
Animal Replacement Technologies announced today the launch of their second-generation arterial lesions. These lesions are more sophisticated that the original chronic total occlusion models, and are designed to integrate with the company\'s current peripheral, coronary, and cerebral vascular products. these may be mounted in straight or branched sections as small as 1mm in diameter, may be softcap or hardcap, chronic total occlusions or characterized by a particular TIMI flow, and…
Animal Replacement Technologies - Chief Operating Officer Search
Animal Replacement Technologies announced today the opening of a search for the position of Chief Operating Officer. This new position shall report directly to the President, and will carry executive responsibility for fundraising, sales and marketing, and general business administration. The individual ideally suited for this position will have an MBA from a reputable university and executive-level experience in the medical device, pharmaceutical, or biotechnology industries.
Animal Replacement Technologies, based in…
More Releases for Christopher
Christopher Flinos: Pioneering Greece's Blockchain Revolution
An Exclusive Interview on Regulation, Innovation, and the Road Ahead
Interviewer: Christopher, since moving on from HAYVN, you've been working on something ambitious over the last 12 months - creating a blockchain and cryptocurrency framework for Greece. What led you to take on this challenge?
Christopher Flinos: Greece has immense untapped potential, but its economy has been struggling for years. Austerity measures, high unemployment, and brain drain have left an entire generation…
Christopher Flinos: Building Greece's Blockchain Future
An Exclusive Interview on Regulation, Innovation, and the Road Ahead
Interviewer: Christopher, since moving on from HAYVN, you've been working on something ambitious over the last 12 months - creating a blockchain and cryptocurrency framework for Greece. What led you to take on this challenge?
Christopher Flinos: Greece has immense untapped potential, but its economy has been struggling for years. Austerity measures, high unemployment, and brain drain have left an entire generation…
Christopher Bentley Has Joined the Healthcare Team
Christopher Bentley, a U.S. trader and private wealth manager, has joined the healthcare team led by Jason Robson BSc, focusing on biotech and pharmaceutical equities. After 8 years at Monocom Markets in Tokyo, Christopher now holds the title of senior team member.
Previously, he was one of six sector brokers at Monocom Markets, working under the Director of Operations & Discretionary Accounts, Isaac Dreyfuss MBA. Mr. Dreyfuss commented, "Christopher thrives in…
Christopher Hildebrant: Cincinnati's Rising Entrepreneurial Star
Image: https://www.getnews.info/wp-content/uploads/2024/06/1719257217.png
Christopher Hildebrant Cincinnati
Christopher Hildebrant has emerged as a prominent figure in Cincinnati's business landscape, making significant real estate development and entrepreneurship strides.
As the founder and CEO of a successful real estate development firm, Hildebrant has been instrumental in reshaping Cincinnati's urban landscape. His company has spearheaded numerous projects contributing to the city's economic growth and revitalization.
Christopher Hildebrant began with a vision to transform underutilized spaces into vibrant, mixed-use developments.…
Christopher Lee’s Evil Laugh Competition Unearthed
London, United Kingdom: Whilst conducting the digital remastering process on his collected musical works, Mel Croucher unearthed a never-heard-before gem: An ‘evil laugh’ competition between Christopher Lee and fellow actor Joaquim de Almeida.
In the days when computer games came on cassette, Automata were well known for including music tracks on the reverse side as a ‘bonus’ for the players. The Games Collector, a UK-based company is now selling those music…
Austin Bankruptcy Attorney Christy B. Christopher
The Law Office of Christy B. Christopher (www.austintxbankruptcylawyer.net) helps individuals in the Austin, Texas, area with Chapter 7 bankruptcy, Chapter 13 bankruptcy, foreclosures, loan modifications and creditor settlements.
A business or an individual can declare bankruptcy once they have determined it is impossible to pay off their creditors. Bankruptcy gives people a chance to start over from a financial point of view, as it enables them to relieve most types of…
